Quang X. Pham is CEO & Chairman +2 at Cadrenal Therapeutics, Inc. (CVKD). They have made 4 open-market trades across 1 company since 2023, most recently 2026-06-29.
CIK 0001405290
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $100K since 2023, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CVKD | 98,589 | $107K |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CVKD | SELL · 10b5-1 | 2026-06-29 | 2026-07-01 | $3.03 | $22K | -32.6% | -42.7% | -69.3% |
| CVKD | SELL · 10b5-1 | 2026-06-25 | 2026-06-26 | $3.04 | $34K | +0.0% | -33.8% | -59.4% |
| CVKD | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $3.48 | $40K | +11.0% | -29.8% | -61.8% |
| CVKD | SELL · 10b5-1 | 2026-06-16 | 2026-06-18 | $3.18 | $13K | -15.2% | -40.7% | -70.4% |
| CVKD | SELL · 10b5-1 | 2026-06-11 | 2026-06-15 | $3.88 | $70K | -3.1% | -21.9% | -64.8% |
| CVKD | SELL · 10b5-1 | 2026-06-08 | 2026-06-10 | $4.17 | $93K | -23.2% | -29.2% | -70.6% |
| CVKD | SELL · 10b5-1 | 2026-06-03 | 2026-06-05 | $4.37 | $36K | -23.8% | -24.0% | -71.0% |
| CVKD | SELL · 10b5-1 | 2026-05-29 | 2026-06-02 | $4.72 | $3K | -9.1% | -15.4% | -60.5% |
| CVKD | SELL · 10b5-1 | 2026-05-22 | 2026-05-26 | $5.69 | $7K | -17.7% | -45.4% | -70.5% |
| CVKD | SELL · 10b5-1 | 2026-05-11 | 2026-05-29 | $5.44 | $69K | -15.5% | -38.8% | -68.1% |
| CVKD | SELL · 10b5-1 | 2025-10-24 | 2025-10-28 | $14.01 | $34K | -5.6% | -27.0% | -40.1% |
| CVKD | SELL · 10b5-1 | 2025-10-09 | 2025-10-14 | $14.09 | $51K | +1.5% | -16.3% | -38.7% |
| CVKD | SELL · 10b5-1 | 2025-10-02 | 2025-10-03 | $14.13 | $7K | +0.8% | -3.3% | -47.5% |
| CVKD | SELL · 10b5-1 | 2025-09-29 | 2025-10-01 | $14.01 | $18K | -2.0% | -4.2% | -53.6% |
| CVKD | SELL | 2025-09-24 | 2025-09-26 | $14.07 | $227K | -0.4% | -6.5% | -47.1% |
| CVKD | SELL | 2025-08-27 | 2025-08-29 | $13.99 | $124K | +7.9% | +7.3% | -25.0% |
| CVKD | BUY | 2023-09-05 | 2023-09-06 | $0.91 | $36K | -18.6% | -28.5% | -46.8% |
| CVKD | BUY | 2023-09-01 | 2023-09-05 | $0.91 | $64K | -14.0% | -29.6% | -46.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.